U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794853) titled 'Mechanism of Transjugular Intrahepatic Portosystemic Shunt to Improve Sarcopenia' on Jan. 20.
Brief Summary: Sarcopenia is particularly common in patients with chronic liver disease, especially in patients with decompensated cirrhosis, where the prevalence can be more than 50%. Sarcopenia is an important risk factor for a significant increase in mortality in cirrhotic patients, and is closely associated with a high incidence of complications such as hepatic encephalopathy, ascites, and infections . Recent studies have found that TIPS not only significantly improves clinical symptoms caused by portal hypertension, but may also have a...